Database Exploitation Could Slash Clinical Trial Durations, Cut Costs
This article was originally published in The Pink Sheet Daily
Executive Summary
A presentation by health care consultancy VitalTransformation shows that a fifth could be cut off clinical trial times and up to $300 million saved if databases were used for trial recruitment.
You may also be interested in...
Ebola Threat Prompts EU To Focus On Adaptive Licensing
The spread of Ebola to Europe is prompting regulators and industry to explore in more detail adaptive licensing pathways to speed access to potentially life-saving drugs.
MEPs Pass Clinical Trials Laws But Implementation Will Be Troublesome
Europe’s parliamentarians have unsurprisingly and overwhelmingly voted in favor of the Clinical Trials Regulation – but implementation and transparency problems hover on the horizon.
MHRA’s Beneficial EU Relationship And Profitable Synergies With NICE: An Interview With Michael Rawlins
In December, Michael Rawlins was appointed head of the U.K.’s Medicines and Healthcare products Regulatory Agency. He recognizes the MHRA’s mutually beneficial relationship with European counterparts and is looking to safeguard synergies with other national regulatory bodies and NICE.